Minor
SABLe · Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients
Primary completion date changed from estimate of Aug 1, 2025 to Dec 1, 2025
Ida Bruun KristensenPhase 2 NCT04717700 Registry history of NCT04717700 on ClinicalTrials.gov (opens the registry)